Handelsbanken Fonder’s Exact Sciences EXAS Stock Holding History

Handelsbanken Fonder’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-56,200	Closed	-$5.71M	–	1507
2025 Q4	$5.71M	Buy	56,200 +7,000	+14%	+$562K	0.02%	466
2025 Q3	$2.69M	Hold	49,200	–	–	0.01%	636
2025 Q2	$2.61M	Hold	49,200	–	–	0.01%	573
2025 Q1	$2.13M	Hold	49,200	–	–	0.01%	631
2024 Q4	$2.77M	Buy	49,200 +600	+1%	+$37.3K	0.01%	566
2024 Q3	$3.31M	Buy	48,600 +9,400	+24%	+$530K	0.01%	515
2024 Q2	$1.66M	Buy	39,200 +800	+2%	+$44K	0.01%	638
2024 Q1	$2.65M	Buy	38,400 +4,200	+12%	+$266K	0.01%	540
2023 Q4	$2.53M	Buy	34,200 +300	+0.9%	+$19.7K	0.01%	511
2023 Q3	$2.31M	Buy	33,900 +4,200	+14%	+$356K	0.01%	519
2023 Q2	$2.79M	Buy	29,700 +500	+2%	+$39K	0.01%	498
2023 Q1	$1.98M	Buy	29,200 +4,200	+17%	+$270K	0.01%	537
2022 Q4	$1.24M	Buy	25,000 +8,145	+48%	+$333K	0.01%	602
2022 Q3	$548K	Hold	16,855	–	–	﹤0.01%	905
2022 Q2	$664K	Sell	16,855 -42,971	-72%	-$2.3M	﹤0.01%	851
2022 Q1	$4.18M	Buy	59,826 +4,380	+8%	+$320K	0.02%	473
2021 Q4	$4.32M	Sell	55,446 -214,817	-79%	-$19M	0.02%	500
2021 Q3	$25.8M	Buy	270,263 +30,000	+12%	+$3.17M	0.14%	170
2021 Q2	$29.9M	Buy	240,263 +11,268	+5%	+$1.34M	0.16%	151
2021 Q1	$30.2M	Sell	228,995 -23,700	-9%	-$3.24M	0.17%	131
2020 Q4	$33.5M	Sell	252,695 -60,000	-19%	-$7.26M	0.2%	111
2020 Q3	$31.9M	Sell	312,695 -135,700	-30%	-$11.7M	0.23%	93
2020 Q2	$39M	Sell	448,395 -16,568	-4%	-$1.32M	0.33%	73
2020 Q1	$27M	Buy	464,963 +66,013	+17%	+$5.36M	0.58%	56
2019 Q4	$36.9M	Buy	398,950 +146,950	+58%	+$12.9M	0.64%	50
2019 Q3	$22.8M	Buy	252,000 +62,000	+33%	+$7.06M	0.46%	65
2019 Q2	$22.4M	Buy	190,000 +30,000	+19%	+$3.02M	0.42%	68
2019 Q1	$13.9M	Sell	160,000 -59,100	-27%	-$5.03M	0.27%	93
2018 Q4	$13.8M	Sell	219,100 -8,900	-4%	-$611K	0.28%	99
2018 Q3	$18M	Buy	228,000 +15,000	+7%	+$978K	0.34%	91
2018 Q2	$12.7M	Sell	213,000 -9,000	-4%	-$484K	0.25%	110
2018 Q1	$8.95M	Buy	222,000 +75,000	+51%	+$3.66M	0.18%	120
2017 Q4	$7.72M	Sell	147,000 -16,000	-10%	-$854K	0.17%	113
2017 Q3	$7.68M	Sell	163,000 -7,000	-4%	-$282K	0.18%	114
2017 Q2	$6.01M	Buy	+170,000	New	+$5.25M	0.15%	122

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Handelsbanken Fonder's EXAS Position: Q1 2026 in Review

Handelsbanken Fonder sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 56,200 shares — an estimated $5.71M sold.

Handelsbanken Fonder first reported a position in EXAS in Q2 2017 and held it in 35 quarters. The position peaked at $39M in Q2 2020. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Handelsbanken Fonder reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Handelsbanken Fonder sold 56,200 Exact Sciences shares in Q1 2026, an estimated $5.71M.
Handelsbanken Fonder first reported a position in Exact Sciences in Q2 2017 and held it in 35 quarters.
Handelsbanken Fonder's Exact Sciences position peaked at $39M in Q2 2020.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Handelsbanken Fonder's 13F filing for Q1 2026, filed 28 Apr 2026.